 |
Recombinant anti-CD40 monoclonal antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2005-08-12 00:00:00 |
| Sponsor | Novartis Pharmaceutical Corporation;Oncology Business Unit, One Health Plaza, Bldg 104;East Hanover, New Jersey, 07936 |
